Subclasses of external adenosine receptors.
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Cell surface adenosine receptors mediate either stimulation or inhibition of adenylate cyclase activity [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1], and the receptors that mediate these different responses can be discriminated with selected adenosine analogs. 5'-N-Ethylcarboxamide-adenosine is a more potent agonist at stimulatory receptors (Ra) than is N6-phenylisopropyladenosine, whereas the reverse potency order is seen with inhibitory receptors (Ri). The potency of adenosine is intermediate between the potencies of these two analogs. The relative potencies of adenosine receptor agonists are maintained in physiological responses in intact cells, such as steroidogenesis and inhibition of lipolysis. As with adrenergic receptors, subclasses of adenosine receptors differ functionally and pharmacologically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
A highly sensitive adenylate cyclase assay
Salomon, Y., Londos, C., & Rodbell, M. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90222-x · Cited by 4,169
Self-citationThe role of hormone receptors and GTP-regulatory proteins in membrane transduction
Rodbell, M. (1980) · Nature · doi:10.1038/284017a0 · Cited by 1,749
SATTIN, A., & RALL, T. W. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15197-3 · Cited by 892
Two distinct adenosine-sensitive sites on adenylate cyclase.
Londos, C., & Wolff, J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5482 · Cited by 574
Self-citationThe Glucagon-sensitive Adenyl Cyclase System in Plasma Membranes of Rat Liver
Pohl, S. L., Birnbaumer, L., & Rodbell, M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62386-5 · Cited by 520
Adenosine as inhibitor of myocardial effects of catecholamines
Schrader, J., Baumann, G., & Gerlach, E. (1977) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00582203 · Cited by 360
Sabol, S. L., & Nirenberg, M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37743-8 · Cited by 287
Potentiation of Mast Cell Mediator Release by Adenosine
Marquardt, D. L., Parker, C. W., & Sullivan, T. J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.871 · Cited by 267
Londos, C., Cooper, D. M., Schlegel, W., & Rodbell, M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5362 · Cited by 251
Self-citation
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,585
Nehlig, A., Daval, J.-L., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,461
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Is there a basis for distinguishing two types of P2-purinoceptor?
Burnstock, G., & Kennedy, C. (1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90001-1 · Cited by 1,365
Purinoceptors: Are there families of P2X and P2Y purinoceptors?
Abbracchio, M. P., & Burnstock, G. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00048-4 · Cited by 1,083
Purine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
Burnstock, G., & Knight, G. E. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)40002-3 · Cited by 795
The cardiac effects of adenosine
Belardinelli, L., Linden, J., & Berne, R. M. (1989) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(89)90015-7 · Cited by 762
Klotz, K.-N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B. B., & Lohse, M. J. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005131 · Cited by 723
Adenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
Fredholm, B. B., Chen, J.-F., Cunha, R. A., Svenningsson, P., & Vaugeois, J.-M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 692
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 650
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
The Physiological Role of Adenosine In The Central Nervous System
Dunwiddie, T. V. (1985) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60556-5 · Cited by 623
Synaptic Control of Motoneuronal Excitability
Rekling, J. C., Funk, G. D., Bayliss, D. A., Dong, X.-W., & Feldman, J. L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.2.767 · Cited by 607
The past, present and future of purine nucleotides as signalling molecules
Burnstock, G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00125-1 · Cited by 543
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Thompson, S. M., Haas, H. L., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019168 · Cited by 480
Roles of P2-purinoceptors in the cardiovascular system.
Ralevic, V, & Burnstock, G. (1991) · Circulation · doi:10.1161/01.cir.84.1.1 · Cited by 472
Signalling from adenosine receptors to mitogen-activated protein kinases
Schulte, G., & Fredholm, B. B. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00058-5 · Cited by 471
Feoktistov, I., & Biaggioni, I. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01339-5 · Cited by 421
Protective effects of adenosine in myocardial ischemia.
Ely, S. W., & Berne, R. M. (1992) · Circulation · doi:10.1161/01.cir.85.3.893 · Cited by 412
Sun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., Briggs, J., & Schnermann, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171317998 · Cited by 404
Trophic effects of purines in neurons and glial cells
Rathbone, M. P., Middlemiss, P. J., Gysbers, J. W., Andrew, C., Herman, M. A. R., Reed, J. K., Ciccarelli, R., Di Iorio, P., & Caciagli, F. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00017-9 · Cited by 398
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Lohse, M. J., Klotz, K.-N., Lindenborn-Fotinos, J., Reddington, M., Schwabe, U., & Olsson, R. A. (1987) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00165806 · Cited by 393
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
Yang, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27933 · Cited by 349
Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action
Magkos, F., & Kavouras, S. A. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040-830491379245 · Cited by 344
Reppert, S. M., Weaver, D. R., Stehle, J. H., & Rivkees, S. A. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1037 · Cited by 336
Purine and purinergic receptors
Burnstock, G. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818817494 · Cited by 329
Adenosine receptors and their ligands
Klotz, K.-N. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000315 · Cited by 327
Pharmacology of adenosine A2A receptors
Ongini, E., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)80010-1 · Cited by 321
Adenosine receptors and calcium: Basis for proposing a third (A3) adenosine receptor
Ribeiro, J. A., & Sebastião, A. M. (1986) · Progress in Neurobiology · doi:10.1016/0301-0082(86)90015-8 · Cited by 282
Adenosine receptors: new opportunities for future drugs
Poulsen, S.-A., & Quinn, R. J. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00038-8 · Cited by 280
Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype
Stehle, J. H. (1992) · Molecular Endocrinology · doi:10.1210/me.6.3.384 · Cited by 275
Burnstock, G. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451014 · Cited by 266
X-ray structures define human P2X3 receptor gating cycle and antagonist action
Mansoor, S. E., Lü, W., Oosterheert, W., Shekhar, M., Tajkhorshid, E., & Gouaux, E. (2016) · Nature · doi:10.1038/nature19367 · Cited by 258
Dolphin, A. C., Forda, S. R., & Scott, R. H. (1986) · The Journal of Physiology · doi:10.1113/jphysiol.1986.sp016034 · Cited by 254
Xanthine derivatives as adenosine receptor antagonists
Fredholm, B. B., & Persson, C. G. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90359-4 · Cited by 237
Adenosine and ATP Receptors in the Brain
Burnstock, G., B. Fredholm, B., & Verkhratsky, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347627 · Cited by 190
Montesinos, M. C., Yap, J. S., Desai, A., Posadas, I., McCrary, C. T., & Cronstein, B. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<656::aid-anr23>3.0.co;2-h · Cited by 186
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
Schwabe, U., Ukena, D., & Lohse, M. J. (1985) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00572436 · Cited by 153
Mediero, A., & Cronstein, B. N. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.02.001 · Cited by 133
“A2A Adenosine ATL146e CGS21680 Regadenoson HE-NECA CVT3146 Caffeine Theophylline Istradefylline SCH58261 SCH442416 ZM241385 KF17837 KW6002 GS increase cAMP [3-8]”
BackgroundInfluentialLai, H.-L., Yang, T.-H., Messing, R. O., Ching, Y.-H., Lin, S.-C., & Chern, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4970 · Cited by 129
Adenosine receptor neurobiology: overview
Chen, J.-F., Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00001-5 · Cited by 119
Cardiovascular effects of adenosine
Fredholm, B. B., & Sollevi, A. (1986) · Clinical Physiology · doi:10.1111/j.1475-097x.1986.tb00139.x · Cited by 115
Mediero, A., Perez‐Aso, M., & Cronstein, B. N. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12227 · Cited by 93
Clark, R. S. B., Carcillo, J. A., Kochanek, P. M., Obrist, W. D., Jackson, E. K., Mi, Z., Wisneiwski, S. R., Bell, M. J., & Marion, D. W. (1997) · Neurosurgery · doi:10.1097/00006123-199712000-00010 · Cited by 91
Metadata
- Authors
- Londos, C., Cooper, D. M., & Wolff, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1980-05
- Volume
- 77
- Issue
- 5
- Pages
- 2551-2554
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2007462827
- Cited by
- 1,081
- References
- 13
- FWCI
- 20.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.